View drug registration information details.
Items | Registration information |
ID | 320 |
No | 320 |
Brand Name | HOVID SULBACYN FOR INJECTION 1.5 G |
Ingredients | AMPICILLIN SODIUM EQ.TO AMPICILLIN 1 G AND SULBACTAM SODIUM EQ.TO SULBACTAM 0.5 G |
Dosage Form | POWDER FOR INJECTION |
Primary Packaging | VIAL |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 1.5 G/VIAL, BOX OF 1'S, 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | SKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY BETA-LACTAMASE PRODUCING STRAINS OF STAPHYLOCOCCUS AUREUS, E.COLI. KLEPSIELLA SPP. (INCLUDING K.PNEUMONIAE), PROTEUS MIRABILIS, BACTEROIDES FRAGILIS, ENTEROBACTER SPP., AND ACINETOBACTER CALCOACETICUS. INTRA-ABDOMINAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, KLEPSIELLA SPP, (INCLUDING K.PNEUMONIAE), BACTEROIDES SPP. (INCLUDING B.FRAGILIS), AND ENTEROBACTER SPP. GYNECOLOGICAL INFECTIONS CAUSED BY BETA-LATAMASE PRODUCING STRAINS OF E.COLI, BACTEROIDES SPP. (INCLUDING B.FRAGILIS). |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE TO OFF WHITE POWDER |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | REYOUNG PHARMACEUTICAL CO., LTD |
Country | MALAYSIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 06 I 5540/23 |
FDD Registration Date | 26-Jun-2023 |
Expiry Date | 25-Jun-2026 |
Back to drug list
|